EGFR and glioblastoma: In this study, we discovered widespread chromatin organization alterations of EGFR-amplified glioblastoma at the compartment, TAD, and loop levels, which contribute to oncogene activation and tumor repressor deactivation in EGFR-amplified glioblastoma.